Though a seasoned medicinal chemist's intuition can clearly identify potential problems with small-molecule structures (for example, see the insightful comments provided by G. Rishton in the ...

Figure 1: Examples of small-molecule inhibitors of PPI targets. The ideal small-molecule drug target has a structure that falls into a class known to be 'druggable' and has well-understood biology ...

In an era where technological advancements are constantly reshaping the landscape of the pharmaceutical industry, Protheragen-ING has emerged as a frontrunner with its cutting-edge AI-synthesizer for ...

The Small Molecule Drug Discovery Market size is expected to be worth around USD 121.8 billion by 2033 from USD 52.5 billion in 2023, growing at a CAGR of 8.8% ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...